BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37856205)

  • 1. The Diagnostic Yield of Genetic Testing in Patients With Multiple Colorectal Adenomas: A Specialist Center Cohort Study.
    Mak S; Alexander JL; Clark SK; Hawkins M; Cuthill V; Latchford A; Monahan KJ
    Clin Transl Gastroenterol; 2024 Jan; 15(1):e00645. PubMed ID: 37856205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.
    Grover S; Kastrinos F; Steyerberg EW; Cook EF; Dewanwala A; Burbidge LA; Wenstrup RJ; Syngal S
    JAMA; 2012 Aug; 308(5):485-492. PubMed ID: 22851115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
    Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
    Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP.
    Cheng TH; Gorman M; Martin L; Barclay E; Casey G; ; ; Saunders B; Thomas H; Clark S; Tomlinson I
    Eur J Hum Genet; 2015 Feb; 23(2):260-3. PubMed ID: 24801760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas.
    Belhadj S; Quintana I; Mur P; Munoz-Torres PM; Alonso MH; Navarro M; Terradas M; Piñol V; Brunet J; Moreno V; Lázaro C; Capellá G; Valle L
    Sci Rep; 2019 Jun; 9(1):9020. PubMed ID: 31227763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility gene card for: MUTYH-associated polyposis (MAP), autosomal recessive colorectal adenomatous polyposis, multiple colorectal adenomas, multiple adenomatous polyps (MAP) - update 2012.
    Aretz S; Genuardi M; Hes FJ
    Eur J Hum Genet; 2013 Jan; 21(1):. PubMed ID: 22872101
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations.
    Thirlwell C; Howarth KM; Segditsas S; Guerra G; Thomas HJ; Phillips RK; Talbot IC; Gorman M; Novelli MR; Sieber OM; Tomlinson IP
    Br J Cancer; 2007 Jun; 96(11):1729-34. PubMed ID: 17505512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of colorectal adenomas and cancer in monoallelic carriers of MUTYH pathogenic variants: a single-centre experience.
    Patel R; McGinty P; Cuthill V; Hawkins M; Clark SK; Latchford A
    Int J Colorectal Dis; 2021 Oct; 36(10):2199-2204. PubMed ID: 34244858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Multiple Colorectal Adenoma Patients Without Germline APC or MYH Mutations.
    Tieu AH; Edelstein D; Axilbund J; Romans KE; Brosens LA; Wiley E; Hylind L; Giardiello FM
    J Clin Gastroenterol; 2016 Aug; 50(7):584-8. PubMed ID: 26485104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.
    Sieber OM; Lipton L; Crabtree M; Heinimann K; Fidalgo P; Phillips RK; Bisgaard ML; Orntoft TF; Aaltonen LA; Hodgson SV; Thomas HJ; Tomlinson IP
    N Engl J Med; 2003 Feb; 348(9):791-9. PubMed ID: 12606733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic Phenotype of Monoallelic Carriers of MUTYH Gene Mutations in the Family of Polyposis Patients: A Prospective Study.
    El Hachem N; Abadie C; Longy M; Colas C; Fert-Ferrer S; Leroux D; Grandval P; Prieur F; Collonge-Rame M; Faivre L; Fricker JP; Zerbib F; Coupier I; Cauchin E; Pinson S; Saurin JC
    Dis Colon Rectum; 2019 Apr; 62(4):470-475. PubMed ID: 30640315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated polyposis of the large bowel: a morphologic and molecular approach.
    de Leon MP; Pedroni M; Roncucci L; Domati F; Rossi G; Magnani G; Pezzi A; Fante R; Bonetti LR
    Fam Cancer; 2017 Apr; 16(2):211-220. PubMed ID: 27783336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Germline Mutations in Polyposis and Colorectal Cancer-Associated Genes in Patients With Multiple Colorectal Polyps.
    Stanich PP; Pearlman R; Hinton A; Gutierrez S; LaDuca H; Hampel H; Jasperson K
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2008-2015.e3. PubMed ID: 30557735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals.
    Ukaegbu C; Levi Z; Fehlmann TD; Uno H; Chittenden A; Inra JA; Grover S; Kastrinos F; Syngal S; Yurgelun MB
    Fam Cancer; 2021 Apr; 20(2):111-116. PubMed ID: 32743790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.
    Rosner G; Bercovich D; Daniel YE; Strul H; Fliss-Isakov N; Ben-Yehoiada M; Santo E; Halpern Z; Kariv R
    Fam Cancer; 2015 Sep; 14(3):427-36. PubMed ID: 25822476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal Adenomas in Patients With Multiple Colorectal Adenomas Without Germline APC or MUTYH Mutations.
    Kallenberg FGJ; Latchford A; Lips NC; Aalfs CM; Bastiaansen BAJ; Clark SK; Dekker E
    Dis Colon Rectum; 2018 Jan; 61(1):58-66. PubMed ID: 29215473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Declining detection rates for APC and biallelic MUTYH variants in polyposis patients, implications for DNA testing policy.
    Terlouw D; Suerink M; Singh SS; Gille HJJP; Hes FJ; Langers AMJ; Morreau H; Vasen HFA; Vos YJ; van Wezel T; Tops CM; Ten Broeke SW; Nielsen M
    Eur J Hum Genet; 2020 Feb; 28(2):222-230. PubMed ID: 31527860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis?
    Aimé A; Coulet F; Lefevre JH; Colas C; Cervera P; Flejou JF; Lascols O; Soubrier F; Parc Y
    Cancer Genet; 2015; 208(7-8):390-5. PubMed ID: 26056087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative DNA damage drives carcinogenesis in MUTYH-associated-polyposis by specific mutations of mitochondrial and MAPK genes.
    Venesio T; Balsamo A; Errichiello E; Ranzani GN; Risio M
    Mod Pathol; 2013 Oct; 26(10):1371-81. PubMed ID: 23599153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.